Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

BMG Labtech Presents its Newest HTS Technology at European Laboratory Automation 2012

Published: Tuesday, May 22, 2012
Last Updated: Tuesday, May 22, 2012
Bookmark and Share
In Hamburg, Germany on May 30-31st BMG LABTECH, the Microplate Reader Company, will showcase its newest technology at ELA 2012.

Stop by Booth #120 to see unique and proprietary microplate reader technology that separates BMG LABTECH from the rest. BMG LABTECH features not found on any other instrument, include: ultra-fast, full spectrum (220-1000 nm) absorbance analysis for chemical or biological samples; laser-based,NEPHELOstarPlus_ACU.gif light-scattering nephelometery for measuring compound solubility; Atmospheric Control Unit (ACU) for optimizing cell-based assay experiments or for inducing disease states such as hypoxia; and Direct Optic Bottom reading for unmatched signal-to-noise ratios in all fluorescent protein assays such as GFP, YFP and mCherry.

BMG LABTECH will also highlight their microplate readers in several application posters. One poster, presented in conjunction with Pharma Diagnostics, will show how the SoPRanoTM label-free technology is easily executed on a BMG LABTECH spectrometer-based microplate reader. When proteins bind to the SoPRanoTM Gold-Nano Rods, there is a shift in the ODmax. This ODmax shift is easily monitored with a BMG LABTECH spectrometer-based instrument, which can capture a full spectrum in less than one second per well. This allows protein-protein interactions to be readily monitored with this system. Another poster, in conjunction with BellBrook Laboratories, describes the generic Transcreener® FP assay platform that can be used to measure a diverse set of enzymes in an HTS format, including Methyltransferase, Acetyltransferase, Kinases, ATPases, and GTPases. These robust and highly reproducible assays were performed on the PHERAstar Plus HTS instrument using Simultaneous Dual Emission (SDE) detection. Simultaneous Dual Emission Detection substantially reduces plate read times and it corrects for any signal variations due to differences in well volumes, concentrations, or fluctuations in excitation energy.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos